2018
DOI: 10.1002/cbdv.201800028
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Enantiomerically Enriched Drug Precursors by Lactobacillus paracasei BD87E6 as a Biocatalyst

Abstract: Global sales of single enantiomeric drug products are growing at an alarming rate every year. A total of 7 bacterial strains were screened for their ability to reduce acetophenones to its corresponding alcohol. Among these strains Lactobacillus paracasei BD87E6 was found to be the most successful biocatalyst to reduce the ketones to the corresponding alcohols. The reaction conditions were systematically optimized for the reducing agent Lactobacillus paracasei BD87E6, which showed high enantioselectivity and co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 34 publications
0
5
0
Order By: Relevance
“…The gut microbiota consists of numerous bacterial species dwelling inside the gastrointestinal tract (GIT) existing as symbionts with the human host 16 and is believed to play an essential role in physiology 17,18 . A 51% of gut microbiota are belonging to the Firmicutes phyla comprising the groups of Clostridium coccoides and Clostridium leptum and the most acknowledged Lactobacillus genera and 48% consists of the Bacteroidetes phyla comprising well recognized genera of Prevotella and Bacteroides 19,20 . The remaining 1% of microbiota is the less-known phyla, comprising Proteobacteria, Actinobacteria, Bifidobacteria, Fusobacteria, Spirochaetes, Verrucomicrobia, and Lentispaerae 19,21 .…”
Section: The Gut Microbiota and The Gut-brain Axismentioning
confidence: 99%
See 1 more Smart Citation
“…The gut microbiota consists of numerous bacterial species dwelling inside the gastrointestinal tract (GIT) existing as symbionts with the human host 16 and is believed to play an essential role in physiology 17,18 . A 51% of gut microbiota are belonging to the Firmicutes phyla comprising the groups of Clostridium coccoides and Clostridium leptum and the most acknowledged Lactobacillus genera and 48% consists of the Bacteroidetes phyla comprising well recognized genera of Prevotella and Bacteroides 19,20 . The remaining 1% of microbiota is the less-known phyla, comprising Proteobacteria, Actinobacteria, Bifidobacteria, Fusobacteria, Spirochaetes, Verrucomicrobia, and Lentispaerae 19,21 .…”
Section: The Gut Microbiota and The Gut-brain Axismentioning
confidence: 99%
“…L. plantarum MTCC 1325 was reported to produce acetylcholine (Ach) neurotransmitter which has properties against D-galactose induced AD impairment 1 . L. paracasei BD87E6 was reported to produce (S)-rivastigmine, an anticholinesterase inhibitor that serves the cholinergic hypothesis 20 . A dysregulation in the gut microbiota can lead to AD by regulating short-chain fatty acid (SCFA) 53 .…”
Section: Bifidobacterium Strains Transmission and Brain Metabolism) (L Buchnermentioning
confidence: 99%
“…Enzymes play a crucial role in green chemistry as they function as catalysts, accelerating chemical reactions without requiring harsh reaction conditions or chemicals, and are also reusable. [6][7][8][9][10][11][12][13][14] A chemo-enzymatic strategy via kinetic resolution of cis-(�)-dimethyl 1-acetylpiperidine-2,3-dicarboxylate (cis-13) has been claimed in a patent by FIS Italian Factory Synthetic SPA (Scheme 4). [15] It involves the use of covalently immobilized lipase B from Candida antarctica (CAL B).…”
Section: Introductionmentioning
confidence: 99%
“…In view of green chemistry aspects, biocatalytic approaches have been developed as an alternative to chemical resolution. Enzymes play a crucial role in green chemistry as they function as catalysts, accelerating chemical reactions without requiring harsh reaction conditions or chemicals, and are also reusable [6–14] . A chemo‐enzymatic strategy via kinetic resolution of cis ‐(±)‐dimethyl 1‐acetylpiperidine‐2,3‐dicarboxylate ( cis ‐ 13 ) has been claimed in a patent by FIS Italian Factory Synthetic SPA (Scheme 4).…”
Section: Introductionmentioning
confidence: 99%
“…Biocatalysis can be performed by using whole‐cell microorganism or isolated enzymes as both methods have some advantages and drawbacks (Öksüz et al ., 2018). Whole‐cell biocatalysts are easy to obtain and relatively cheap and more stable, but its catalytic reaction is subject to the influence of other metabolic reactions in the cell, which produce other by‐products, affecting the separation and purification of the target products (Şahin, 2019).…”
Section: Introductionmentioning
confidence: 99%